BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36539890)

  • 1. Definition of a novel breast tumor-specific classifier based on secretome analysis.
    Sirven P; Faucheux L; Grandclaudon M; Michea P; Vincent-Salomon A; Mechta-Grigoriou F; Scholer-Dahirel A; Guillot-Delost M; Soumelis V
    Breast Cancer Res; 2022 Dec; 24(1):94. PubMed ID: 36539890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pleiotropic roles of adipocyte secretome in remodeling breast cancer.
    Zhou X; Zhang J; Lv W; Zhao C; Xia Y; Wu Y; Zhang Q
    J Exp Clin Cancer Res; 2022 Jun; 41(1):203. PubMed ID: 35701840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
    Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
    Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretome of tumor-associated leukocytes augment epithelial-mesenchymal transition in positive lymph node breast cancer patients via activation of EGFR/Tyr845 and NF-κB/p65 signaling pathway.
    Elghonaimy EA; Ibrahim SA; Youns A; Hussein Z; Nouh MA; El-Mamlouk T; El-Shinawi M; Mostafa Mohamed M
    Tumour Biol; 2016 Sep; 37(9):12441-12453. PubMed ID: 27329104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Protein Secretome Is Altered in Rectal Cancer Tissue Compared to Normal Rectal Tissue, and Alterations in the Secretome Induce Enhanced Innate Immune Responses.
    Heeran AB; Dunne MR; Morrissey ME; Buckley CE; Clarke N; Cannon A; Donlon NE; Nugent TS; Durand M; Dunne C; Larkin JO; Mehigan B; McCormick P; Lynam-Lennon N; O'Sullivan J
    Cancers (Basel); 2021 Feb; 13(3):. PubMed ID: 33540635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative secretome analysis reveals the interactions between epithelia and tumor cells by in vitro modulating colon cancer microenvironment.
    Zeng X; Yang P; Chen B; Jin X; Liu Y; Zhao X; Liang S
    J Proteomics; 2013 Aug; 89():51-70. PubMed ID: 23748022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast tumor microenvironment: proteomics highlights the treatments targeting secretome.
    Chen ST; Pan TL; Juan HF; Chen TY; Lin YS; Huang CM
    J Proteome Res; 2008 Apr; 7(4):1379-87. PubMed ID: 18290608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered levels of plasma chemokines in breast cancer and their association with clinical and pathological characteristics.
    Narita D; Seclaman E; Anghel A; Ilina R; Cireap N; Negru S; Sirbu IO; Ursoniu S; Marian C
    Neoplasma; 2016; 63(1):141-9. PubMed ID: 26639244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-derived scaffolds influence secretion profiles in cancer cells mirroring clinical features and breast cancer subtypes.
    Persson E; Gregersson P; Gustafsson A; Fitzpatrick P; Rhost S; Ståhlberg A; Landberg G
    Cell Commun Signal; 2021 Jun; 19(1):66. PubMed ID: 34090457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretome analysis of breast cancer-associated adipose tissue to identify paracrine regulators of breast cancer growth.
    Lapeire L; Hendrix A; Lecoutere E; Van Bockstal M; Vandesompele J; Maynard D; Braems G; Van Den Broecke R; Müller C; Bracke M; Cocquyt V; Denys H; De Wever O
    Oncotarget; 2017 Jul; 8(29):47239-47249. PubMed ID: 28525384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying Molecular Signatures of Distinct Modes of Collective Migration in Response to the Microenvironment Using Three-Dimensional Breast Cancer Models.
    Ardila DC; Aggarwal V; Singh M; Chattopadhyay A; Chaparala S; Sant S
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33804802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early detection of tumor cells by innate immune cells leads to T(reg) recruitment through CCL22 production by tumor cells.
    Faget J; Biota C; Bachelot T; Gobert M; Treilleux I; Goutagny N; Durand I; Léon-Goddard S; Blay JY; Caux C; Ménétrier-Caux C
    Cancer Res; 2011 Oct; 71(19):6143-52. PubMed ID: 21852386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaphylatoxin Receptors C3aR and C5aR1 Are Important Factors That Influence the Impact of Ethanol on the Adipose Secretome.
    McCullough RL; McMullen MR; Poulsen KL; Kim A; Medof ME; Nagy LE
    Front Immunol; 2018; 9():2133. PubMed ID: 30294325
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression of membrane anchored cytokines and B7-1 alters tumor microenvironment and induces protective antitumor immunity in a murine breast cancer model.
    Bozeman EN; Cimino-Mathews A; Machiah DK; Patel JM; Krishnamoorthy A; Tien L; Shashidharamurthy R; Selvaraj P
    Vaccine; 2013 May; 31(20):2449-56. PubMed ID: 23541884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micro-RNA193a-3p Inhibits Breast Cancer Cell Driven Growth of Vascular Endothelial Cells by Altering Secretome and Inhibiting Mitogenesis: Transcriptomic and Functional Evidence.
    Azzarito G; Kurmann L; Leeners B; Dubey RK
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory Breast Cancer: The Secretome of HCMV
    Mohamed HT; El-Sharkawy AA; El-Shinawi M; Schneider RJ; Mohamed MM
    Front Oncol; 2022; 12():899622. PubMed ID: 35847899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the Cancer Cell Secretome in Driving Breast Cancer Progression.
    Zahari S; Syafruddin SE; Mohtar MA
    Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of CXCL13 and CXCL9 in Early Breast Cancer.
    Razis E; Kalogeras KT; Kotsantis I; Koliou GA; Manousou K; Wirtz R; Veltrup E; Patsea H; Poulakaki N; Dionysopoulos D; Pervana S; Gogas H; Koutras A; Pentheroudakis G; Christodoulou C; Linardou H; Pavlakis K; Koletsa T; Pectasides D; Zagouri F; Fountzilas G
    Clin Breast Cancer; 2020 Feb; 20(1):e36-e53. PubMed ID: 31699671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1-induced changes in the glioblastoma secretome suggest its role in tumor progression.
    Tarassishin L; Lim J; Weatherly DB; Angeletti RH; Lee SC
    J Proteomics; 2014 Mar; 99():152-168. PubMed ID: 24503185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.